These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 21395580

  • 41. RIP1 mediates the protection of geldanamycin on neuronal injury induced by oxygen-glucose deprivation combined with zVAD in primary cortical neurons.
    Chen WW, Yu H, Fan HB, Zhang CC, Zhang M, Zhang C, Cheng Y, Kong J, Liu CF, Geng D, Xu X.
    J Neurochem; 2012 Jan; 120(1):70-7. PubMed ID: 21985437
    [Abstract] [Full Text] [Related]

  • 42. ATP analog enhances the actions of a heat shock protein 90 inhibitor in multiple myeloma cells.
    Cervantes-Gomez F, Nimmanapalli R, Gandhi V.
    J Pharmacol Exp Ther; 2011 Nov; 339(2):545-54. PubMed ID: 21821695
    [Abstract] [Full Text] [Related]

  • 43. Downregulation of Xeroderma Pigmentosum Complementation Group C Expression by 17-Allylamino-17-Demethoxygeldanamycin Enhances Bevacizumab-Induced Cytotoxicity in Human Lung Cancer Cells.
    Chen JC, Ko JC, Taso YC, Cheng HH, Chen TY, Yen TC, Lin YW.
    Pharmacology; 2021 Nov; 106(3-4):154-168. PubMed ID: 33202406
    [Abstract] [Full Text] [Related]

  • 44. Lectin, Galactoside-Binding Soluble 3 Binding Protein Promotes 17-N-Allylamino-17-demethoxygeldanamycin Resistance through PI3K/Akt Pathway in Lung Cancer Cell Line.
    Woo JK, Jang JE, Kang JH, Seong JK, Yoon YS, Kim HC, Lee SJ, Oh SH.
    Mol Cancer Ther; 2017 Jul; 16(7):1355-1365. PubMed ID: 28336809
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Inhibition of Hsp90 leads to cell cycle arrest and apoptosis in human malignant pleural mesothelioma.
    Okamoto J, Mikami I, Tominaga Y, Kuchenbecker KM, Lin YC, Bravo DT, Clement G, Yagui-Beltran A, Ray MR, Koizumi K, He B, Jablons DM.
    J Thorac Oncol; 2008 Oct; 3(10):1089-95. PubMed ID: 18827603
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Targeting heat shock protein 72 enhances Hsp90 inhibitor-induced apoptosis in myeloma.
    Davenport EL, Zeisig A, Aronson LI, Moore HE, Hockley S, Gonzalez D, Smith EM, Powers MV, Sharp SY, Workman P, Morgan GJ, Davies FE.
    Leukemia; 2010 Oct; 24(10):1804-7. PubMed ID: 20703255
    [No Abstract] [Full Text] [Related]

  • 51. HSP90 inhibitor enhances anti-proliferative and apoptotic effects of celecoxib on HT-29 colorectal cancer cells via increasing BAX/BCL-2 ratio.
    Mohammadi A, Yaghoobi MM, GholamhoseynianNajar A, Kalantari-Khandani B, Sharifi H, Saravani M.
    Cell Mol Biol (Noisy-le-grand); 2016 Oct 31; 62(12):62-67. PubMed ID: 27894402
    [Abstract] [Full Text] [Related]

  • 52. Cooperative enhancement of radiosensitivity after combined treatment of 17-(allylamino)-17-demethoxygeldanamycin and celecoxib in human lung and colon cancer cell lines.
    Kim YM, Pyo H.
    DNA Cell Biol; 2012 Jan 31; 31(1):15-29. PubMed ID: 21830942
    [Abstract] [Full Text] [Related]

  • 53. The HSP90 Inhibitor, 17-AAG, Influences the Activation and Proliferation of T Lymphocytes via AKT/GSK3β Signaling in MRL/lpr Mice.
    Hong LJ, Chen AJ, Li FZ, Chen KJ, Fang S.
    Drug Des Devel Ther; 2020 Jan 31; 14():4605-4612. PubMed ID: 33149557
    [Abstract] [Full Text] [Related]

  • 54. The HSP90 inhibitor 17-AAG exhibits potent antitumor activity for pheochromocytoma in a xenograft model.
    Xu Y, Zhu Q, Chen D, Shen Z, Wang W, Ning G, Zhu Y.
    Tumour Biol; 2015 Jul 31; 36(7):5103-8. PubMed ID: 25682284
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.